Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Microbeam radiation therapy's dose distribution changes with depth.

EPC-CM can reduce skin aging signs by boosting the skin's defense system.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

The new AI software predicts melanoma outcomes more accurately than traditional methods.

GnRH treatment can reduce breast cancer cell invasion.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

MOF controls key genes for skin development by regulating mitochondrial and ciliary functions.